TeinturierC, TournadeMF, Caillat-ZucmanSDiabetes mellitus after abdominal irradiation therapy.Lancet1995; 346: 633–4.
2.
ShaletSM. Radiation and pituitary dysfunction.N Engl J Med1993; 328: 131–3.
3.
SandersJE, BucknerCD, SullivanKM, DoneyK, AppelbaumF, WitherspoonR, StorbR, ThomasED. Growth and development in children after bone marrow transplantation.Horm Res1988; 30: 92–7.
4.
LittleyMD, ShaletSM, BeardwellCG, AhmedSR, ApplegateG, SuttonML. Hypopituitarism following external radiotherapy for pituitary tumours in adults.Q J Med1989; 262: 145–60.
5.
ChiengPU, HuangTS, ChangCCReduced hypothalamic blood flow after radiation treatment of nasopharyngeal cancer: SPECT studies in 34 patients.Am J Nuclear Radiol1991; 12: 661–5.
6.
Ogilvy-StuartAL, WallaceWHB, ShaletSM. Radiation and neuroregulatory control of growth hormone secretion.Clin Endocrinol1994; 41: 163–8.
ShaletSM, PriceDA, BeardwellCG, JonesPH, PearsonD.Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukaemia.J Pediatr1979; 94: 719–22.
9.
ToogoodAA, RyderWDJ, BeardwellCG, ShaletSM. The evolution of radiation-induced growth hormone in adults is determined by the baseline growth hormone status.Clin Endocrinol1995; 43: 97–103.
10.
Ogilvy-StuartAL, ClaytonPE, ShaletSM. Cranial irradiation and early puberty.J Clin Endocrinol Metab1994; 78: 1282–6.
11.
DuffyBJ, FitzgeraldPJ. Thyroid cancer in childhood and adolescence.Cancer1950; 3: 1018–32.
12.
De GrootLJ. Diagnostic approach and management of patients exposed to irradiation to the thyroid.J Clin Endocrinol Metab1989; 69: 925–8.
13.
MaxonHR, ThomasSR, SaengerEL, BuncherCR, KereiakesJG. Ionizing irradiation and the induction of clinically significant disease in the human thyroid gland.Am J Med1977; 63: 967–78.
14.
RonE, ModanB, PrestonD, AlfandaryE, StovallM, BoiceJD. Thyroid neoplasia following low-dose radiation in childhood.Radiat Res1989; 120: 516–31.
15.
SamaanNA, SchultzPN, OrdonezNG, HickeyRC, JohnstonDA. A comparison of thyroid carcinoma in those who have and have not had head and neck irradiation in childhood.J Clin Endocrinol Metab1987; 64: 219–23.
16.
WilliamsD.Thyroid cancer and the Chernobvl accident.J Clin Endocrinol Metab1996; 81: 6–8.
17.
FogelfeldL, WiviottMBT, Shore-FreedmanERecurrence of thyroid nodules after surgical removal in patients irradiated in childhood for benign conditions.N Engl J Med1989; 320: 835–40.
18.
SchimpffSC, DiggsCH, WiswellJG, SalvatorePC, WienikPH. Radiation-related thyroid dysfunction: implications for the treatment of Hodgkin's disease.Ann Intern Med1980; 92: 91–8.
19.
ShaletSM, DidiM, Ogilvy-StuartAL, SchulgaJ, DonaldsonMDC. Growth and endocrine function after bone marrow transplantation.Clin Endocrinol1995; 42: 333–9.
20.
AtkinsMB, MierJW, ParkinsonDR, GouldJA, BerkmanEM, KaplanMM. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells.N Engl J Med1988; 318: 1557–63.
21.
Ogilvy-StuartAL, ShaletSM, GattamaneniHRG. Thyroid function following the treatment of brain tumours in children.J Pediatr1991; 119: 733–7.
HahnEW, FeingoldSM, NisceL.Aspermia and recovery of spermatogenesis in cancer patients following incidental gonadal irradiation during treatment: a progress report.Radiology1976; 119: 223–5.
24.
HahnEW, FeingoldSM, SimpsonL, BatataM.Recovery from aspermia induced by low-dose radiation in seminoma patients.Cancer1982; 50: 337–40.
25.
ShaletSM, TsatsoulisA, WhiteheadE, ReadG.Vulnerability of the human Leydig cell to radiation damage is dose-dependent.J Endocrinol1989; 120: 161–5.
26.
LittleyMD, ShaletSM, MorgensternGR, DeakinDP. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults.Q J Med1991; 287: 265–74.
27.
DollR, SmithPG. The long-term effects of X-irradiation in patients treated for metropathia haemorrhagica.Br J Radiol1968; 41: 362–8.
28.
WallaceWHB, ShaletSM, HendryJH, Morris-JonesPH, GattamaneniHR. Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte.Br Radiol1989; 62: 995–8.
29.
LiFP, GimbrereK, GelberRD, SallanSEOutcome of pregnancy in survivors of Wilms' tumour.JAMA1987; 257: 216–19.
30.
WatsonAR, RanceCP, BainJ.Long-term effects of cyclophosphamide on testicular function.BMJ1985; 291: 1457–60.
31.
WhiteheadE, ShaletSM, BlackledgeG, ToddI, CrowtherD, BeardwellCG. The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male.Cancer1982; 49: 418–22.
32.
HolmesSJ, WhitehouseRW, ClarkST, CrowtherDC, AdamsJE, ShaletSM. Reduced bone mineral density in men following chemotherapy for Hodgkin's disease.Br J Cancer1994; 70: 371–5.
33.
UldallPR, KerrDNS, TacchiD.Sterility and cyclophosphamide.Lancet1972; i: 693–4.
34.
KoyamaH, WadaT, NishizawYCyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer.Cancer1977; 39: 1403–9.
35.
WaldenPAM, BagshaweKD. Pregnancies after chemotherapy for gestational trophoblastic tumours.Lancet1979; ii: 1241.
36.
ChaterjeeR, MillsW, KatzM, McGarrigleHH, GoldstoneAH. Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in post-menarchial female patients.Bone Marrow Transpl1994; 13: 511–17.